Sonoma Pharma jumps on extended Australian approval for sanitizer

Sonoma Pharmaceuticals

15/10/2021 13:25

** Shares of healthcare company  SNOA.O  soar 31% premarket,
set to open at a two-week high of $7.80 
    ** SNOA says Australian Therapeutic Goods Administration has
extended approval for co's Nanocyn disinfectant and sanitizer,
effective against the COVID-19 virus, as a hard-surface
disinfectant  urn:newsml:reuters.com:*:nFWN2RB0PQ
    ** Shares set for their best session in two months 
    ** SNOA down 18% YTD

 (Reporting by Susan Mathew)
 ((susan.mathew@thomsonreuters.com))